Oritavancin Rationale Document
Version 1.0, 2016
DOWNLOAD
Tedizolid Rationale Document
Version 1.0, 2016
DOWNLOAD
Dalbavancin Rationale Document
Version 1.1, 2018
DOWNLOAD
Telavancin Rationale Document
Version 1.0, 2016
DOWNLOAD
Quinolone In Vitro Susceptibility Test Interpretation Criteria Evaluations
Version 1.3, 2018
DOWNLOAD
Aminoglycoside In Vitro Susceptibility Test Interpretation Criteria Evaluations
Version 1.3, 2019
DOWNLOAD
Report on Method Validation and Susceptibility Breakpoint Criteria for Testing Gonococci
Version 1.0, 2019
DOWNLOAD
USCAST Surrogate Guidance Testing Document
Version 1.1, 2018
DOWNLOAD